melior investor partnerships

Partners and Investors

  • Founded in 2008
  • Business model that includes both discovery and clinical development operations.
  • Successful history of partnering and raising capital – $25 million investment from Bukwang Pharmaceuticals for Phase 2b Diabetes development.
  • Seeking investors and partners to co-develop promising pipeline of derisked clinical stage assets in NASH, Diabetes and Parkinson's Disease

If you are interested in learning more about partnering with our team, please contact bizdev@meliorpharma.com to start the conversation.